Published in Lancet on February 14, 1970
Folic acid food fortification-its history, effect, concerns, and future directions. Nutrients (2011) 1.46
The effect of 1 mg folic acid supplementation on clinical outcomes in female migraine with aura patients. J Headache Pain (2016) 0.75
Classical electrostatics in biology and chemistry. Science (1995) 17.26
Ankylosing spondylitis and HL-A 27. Lancet (1973) 11.99
Elective ventilation of potential organ donors. BMJ (1995) 5.50
Reiter's disease and HL-A 27. Lancet (1973) 4.10
Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int (1998) 4.03
Detection and characterisation of an overmodified type III collagen by analysis of non-cutaneous connective tissues in a patient with Ehlers-Danlos syndrome IV. J Med Genet (1992) 3.80
Reconciling the magnitude of the microscopic and macroscopic hydrophobic effects. Science (1991) 3.79
Azathioprine in rheumatoid arthritis. Br Med J (1969) 3.14
Supervision of epileptic patients taking phenytoin. Br Med J (1970) 3.09
Variation of blood-pressure in untreated hypertensive outpatients. Lancet (1969) 2.95
Clinical judgment in rheumatoid arthritis. I. Rheumatologists' opinions and the development of 'paper patients'. Ann Rheum Dis (1983) 2.83
Acute anterior uveitis and HL-A 27. Lancet (1973) 2.74
Extracting hydrophobic free energies from experimental data: relationship to protein folding and theoretical models. Biochemistry (1991) 2.46
Clinical judgment in rheumatoid arthritis. II. Judging 'current disease activity' in clinical practice. Ann Rheum Dis (1983) 2.44
Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene with a frameshift mutation. J Biol Chem (1984) 2.25
Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2. Am J Hum Genet (1990) 2.11
A simple method to measure drug effects on human sperm motility. Br J Clin Pharmacol (1981) 2.06
Inability of rheumatologists to describe their true policies for assessing rheumatoid arthritis. Ann Rheum Dis (1986) 2.06
Why don't doctors use cusums? Lancet (1974) 2.04
Heredopathia atactica polyneuritiformis: Refsum's disease. Acta Neurol Scand (1985) 2.03
Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy. J Immunol (2000) 1.97
Free-energy determinants of alpha-helix insertion into lipid bilayers. Biophys J (1996) 1.89
The inhibitory action of procaine, (+)-propranolol and (+/-)-propranolol on human sperm motility: antagonism by caffeine. Br J Clin Pharmacol (1981) 1.88
Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br Med J (1973) 1.88
Automated ligand placement and refinement with a combined force field and shape potential. Acta Crystallogr D Biol Crystallogr (2006) 1.84
Sleep epilepsy: its pattern and prognosis. Br Med J (1974) 1.76
HL-A 27 and arthropathies associated with ulcerative colitis and psoriasis. Lancet (1974) 1.68
Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44. Am J Hum Genet (1999) 1.68
Epilepsy and other factors in the prognosis of gliomas. Acta Neurol Scand (1980) 1.64
Presenile dementia associated with mosaic trisomy 21 in a patient with a Down syndrome child. Lancet (1989) 1.55
Testing overseas doctors. BMJ (1988) 1.53
Heredopathia atactica polyneuritiformis (refsum's disease) treated by diet and plasma-exchange. Lancet (1979) 1.53
The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2(I) chains which are not incorporated into trimers of type I procollagen. J Biol Chem (1983) 1.52
Familial ataxia, hypogonadism and retinal degeneration. Acta Neurol Scand (1969) 1.47
A trial of oral iron in dialysis patients. Clin Nephrol (1974) 1.42
Trial of three-day and ten-day courses of amoxycillin in otitis media. Br Med J (Clin Res Ed) (1982) 1.33
Clinical judgment in rheumatoid arthritis. III. British rheumatologists' judgments of 'change in response to therapy'. Ann Rheum Dis (1984) 1.33
Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration. J Clin Pharmacol (1996) 1.29
Nuclease S1 mapping of a homozygous mutation in the carboxyl-propeptide-coding region of the pro alpha 2(I) collagen gene in a patient with osteogenesis imperfecta. Proc Natl Acad Sci U S A (1984) 1.29
Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable. J Clin Pharmacol (2000) 1.29
Clinical judgment analysis. Q J Med (1990) 1.28
Antibiotic use in otitis media: patient simulations as an aid to audit. Br Med J (Clin Res Ed) (1981) 1.28
Organ donation. BMJ (1993) 1.27
Ethics and elective ventilation. Br J Hosp Med (1994) 1.25
Effect of weight-loss on plasma and urinary levels of uric acid. Lancet (1972) 1.25
Localized scleroderma and hemiatrophy in association with antibodies to double-stranded DNA. Postgrad Med J (1992) 1.23
Heredopathia atactica polyneuritiformis (Refsum's disease): 1. Clinical features and dietary management. J Hum Nutr (1980) 1.14
The prognosis of petit mal in adults. Epilepsia (1972) 1.13
Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia (1999) 1.11
Clinical variability of osteogenesis imperfecta reflecting molecular heterogeneity: cysteine substitutions in the alpha 1(I) collagen chain producing lethal and mild forms. J Biol Chem (1986) 1.11
Neurological disease in ex-Far-East prisoners of war. Lancet (1980) 1.07
Pharmacokinetics of mycophenolate mofetil (RS61443): a short review. Transplant Proc (1996) 1.05
Effects of chlorpromazine and other drugs acting on the central nervous system on human sperm motility. Eur J Clin Pharmacol (1982) 1.04
Therapeutic monitoring of mycophenolic acid. A consensus panel report. Clin Biochem (1998) 1.01
Staphylococcal septicaemia, endocarditis, and osteomyelitis in dialysis and renal transplant patients. Postgrad Med J (1980) 1.01
Hats for the newborn infant. Br Med J (1979) 0.99
Screening of patients with retinitis pigmentosa for heredopathia atactica polyneuritiformis (Refsum's disease). Br Med J (Clin Res Ed) (1985) 0.98
Hydrocephalus, subarachnoid haemorrhage and ependymomas of the cauda equina. Clin Radiol (1972) 0.98
A flow cytometric immune function assay for human peripheral blood dendritic cells. J Leukoc Biol (2000) 0.97
A clinical comparison of triethanolamine polypeptide oleate-condensate ear drops with olive oil for the removal of impacted wax. Br J Clin Pract (1973) 0.97
The Gaussian Generalized Born model: application to small molecules. Phys Chem Chem Phys (2007) 0.97
Oesophageal dilatation in Parkinson's disease. J Neurol Neurosurg Psychiatry (1974) 0.95
Neurological complications associated with pregnancy. Br J Anaesth (1995) 0.95
Dyspepsia in patients with rheumatoid arthritis. Acta Rheumatol Scand (1966) 0.95
The clinical accountable team. Health Trends (1982) 0.94
delta 9-Tetrahydrocannabinol inhibits human sperm motility. J Pharm Pharmacol (1981) 0.94
Cutaneous aspects of Refsum's disease. J R Soc Med (1991) 0.94
Measurement in clinical trials. Br J Clin Pharmacol (1982) 0.94
Antibiotics for otitis media: can we help doctors agree? Fam Pract (1985) 0.94
Letter: Acute anterior uveitis and HL-A 27. Lancet (1974) 0.94
Baclofen-induced epilepsy. J R Soc Med (1990) 0.94
Perceived numerosity as a function of item size. Percept Mot Skills (1988) 0.93
The treatment of Parkinson's disease--a consumer view. Health Trends (1985) 0.92
Treatment of ocular myasthenia with corticotrophin. J Neurol Neurosurg Psychiatry (1971) 0.92
Skeletal abnormalities in Refsum's disease (heredopathia atactica polyneuritiformis). Br J Radiol (1990) 0.92
Azathioprine in rheumatoid arthritis: double-blind study of full versus half doses versus placebo. Ann Rheum Dis (1981) 0.91
The arthropathy of the Muckle-Wells syndrome. Br J Rheumatol (1994) 0.90
Chlamydia trachomatis and infertility. Lancet (1986) 0.90
Petit-mal status presenting im in middle age. Lancet (1972) 0.90
Controlled trial of physiotherapy and occupational therapy for Parkinson's disease. Br Med J (Clin Res Ed) (1981) 0.90
Action of decamethonium on rat diaphragm. Br J Pharmacol Chemother (1966) 0.90
Residual renal function in hemodialysis patients may protect against hyperaluminemia. Kidney Int (1987) 0.89
Identification of genetic heterogeneity in Refsum's disease. Eur J Hum Genet (2000) 0.88
Determinants of the first decade of bone loss after menopause at spine, hip and radius. QJM (1999) 0.88
Further experience with azathioprine in rheumatoid arthritis. Br Med J (1971) 0.88
Comparison of the growth of the Ehrlich ascites tumor in male and female mice. Cancer Res (1967) 0.87
The significance of plasma phytanic acid levels in adults. J Neurol Neurosurg Psychiatry (1989) 0.87
Clinical and biochemical observations on three cases of hypoxanthine-guanine phosphoribosyltransferase deficiency. Ann Rheum Dis (1975) 0.87
The therapeutic equivalence of oral and intravenous iron in renal dialysis patients. Clin Nephrol (1977) 0.86
Plasma exchange in the treatment of Refsum's disease (heredopathia atactica polyneuritiformis). J Neurol Neurosurg Psychiatry (1991) 0.86
Allopurinol interaction with cyclosporin. BMJ (1994) 0.85
Rat gastric acid secretion in response to graded subcutaneous doses of 2-deoxy-D-glucose. Am J Physiol (1966) 0.85
Morbidity in patients with intracranial gliomas. J Neurol Neurosurg Psychiatry (1983) 0.84
Motor neurone disease and dementia: probably Creutzfeldt-Jakob disease. Proc R Soc Med (1974) 0.84
Refsum disease: the presentation and ophthalmic aspects of Refsum disease in a series of 23 patients. Eye (Lond) (1992) 0.84
Ocular and renal sarcoidosis. J R Soc Med (1995) 0.83
The prognosis of petit mal. Brain (1966) 0.83
Epilepsy. Br Med J (1969) 0.82